Salmonella enterica serovar Typhimurium skills to succeed in the host: virulence and regulation.
Fàbrega A, Vila J.
Clin Microbiol Rev. 2013 Apr;26(2):308-41. doi: 10.1128/CMR.00066-12.
Salmonella Typhimurium screen identifies shifts in mixed-acid fermentation during gut colonization.
Nguyen BD, Sintsova A, Schubert C, Sichert A, Scheidegger C, Näf J, Huttman J, Lentsch V, Keys T, Rutschmann C, Christen P, Kiefer P, Keller P, Barthel M, Cuenca M, Christen B, Sauer U, Slack E, Vorholt JA, Sunagawa S, Hardt WD.
Cell Host Microbe. 2024 Oct 9;32(10):1758-1773.e4. doi: 10.1016/j.chom.2024.08.015. Epub 2024 Sep 17.
Klebsiella oxytoca inhibits Salmonella infection through multiple microbiota-context-dependent mechanisms.
Osbelt L, Almási ÉDH, Wende M, Kienesberger S, Voltz A, Lesker TR, Muthukumarasamy U, Knischewski N, Nordmann E, Bielecka AA, Giralt-Zúñiga M, Kaganovitch E, Kühne C, Baier C, Pietsch M, Müsken M, Greweling-Pils MC, Breinbauer R, Flieger A, Schlüter D, Müller R, Erhardt M, Zechner EL, Strowig T.
Nat Microbiol. 2024 Jul;9(7):1792-1811. doi: 10.1038/s41564-024-01710-0. Epub 2024 Jun 11.
Pathogenesis of Salmonella-induced enteritis.
Santos RL, Tsolis RM, Bäumler AJ, Adams LG.
Braz J Med Biol Res. 2003 Jan;36(1):3-12. doi: 10.1590/s0100-879x2003000100002.
Early Salmonella Typhimurium inoculation may obscure anti-interleukin-10 protective effects on broiler performance during coccidiosis and necrotic enteritis challenge.
Fries-Craft K, Bobeck EA.
Poult Sci. 2024 Jan;103(1):103187. doi: 10.1016/j.psj.2023.103187. Epub 2023 Oct 18.
Assessment of 2 Salmonella enterica serovar Typhimurium-based vaccines against necrotic enteritis in reducing colonization of chickens by Salmonella serovars of different serogroups.
Jiang Y, Kulkarni RR, Parreira VR, Poppe C, Roland KL, Prescott JF.
Can J Vet Res. 2010 Oct;74(4):264-70.
Interpretable machine learning-derived nomogram model for early detection of persistent diarrhea in Salmonella typhimurium enteritis: a propensity score matching based case-control study.
Jin L, Huang Y, Xi J, Zhan L, Jin H, Chen Y, Chu M.
BMC Infect Dis. 2025 Feb 10;25(1):199. doi: 10.1186/s12879-025-10587-1.
Intestinal lysozyme engagement of Salmonella Typhimurium stimulates the release of barrier-impairing InvE and Lpp1.
Han J, Balasubramanian I, Flores JA, Bandyopadhyay S, Yang J, Liu Y, Singh R, Setty P, Kiela P, Ferraris R, Gao N.
J Biol Chem. 2024 Jul;300(7):107424. doi: 10.1016/j.jbc.2024.107424. Epub 2024 May 31.
Targeting tumors with salmonella Typhimurium- potential for therapy.
Wall DM, Srikanth CV, McCormick BA.
Oncotarget. 2010 Dec;1(8):721-728. doi: 10.18632/oncotarget.206.
Epigallocatechin gallate protects mice from Salmonella enterica ser. Typhimurium infection by modulating bacterial virulence through quorum sensing inhibition.
Cheng G, Jian S, Li W, Yan L, Chen T, Cheng T, Liu Z, Ye G, Tang H, Zhang L.
Front Cell Infect Microbiol. 2024 Oct 16;14:1432111. doi: 10.3389/fcimb.2024.1432111. eCollection 2024.
